ProPhase Labs Inc PRPH
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.01–4.21
- Bid/Ask
- $0.01 / $0.01
- Shares Outstanding
- 15.59M
- Market Cap
- $43,580.46
- Volume/Avg
- 152 / 310,421
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.03
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
ProPhase Labs Inc oriented and diversified next generation biotech, genomics and consumer products company that develops and commercializes novel drugs, dietary supplements, and compounds, and human genomic testing. It offer whole genome sequencing and related services. It maintain two operating segments: diagnostic services (which includes its COVID-19 and other diagnostic testing services) and consumer products. It generates majority of revenue from consumer products segment which engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 19
- Website
- https://www.prophaselabs.com
Valuation
|
Metric
|
PRPH
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.03 |
Price/Cash Flow | — |
Price/Earnings
PRPH
Financial Strength
|
Metric
|
PRPH
|
|---|---|
Quick Ratio | 0.03 |
Current Ratio | 0.05 |
Interest Coverage | −2.02 |
Quick Ratio
PRPH
Profitability
|
Metric
|
PRPH
|
|---|---|
Return on Assets (Normalized) | −38.45% |
Return on Equity (Normalized) | −603.49% |
Return on Invested Capital (Normalized) | −133.51% |
Return on Assets
PRPH
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|%n^>L@s | LOCK|s?< | $249B | |||
| Danaher Corp
DHR
| LOCK|v^fJrd&^ | LOCK|%q | $162B | |||
| Agilent Technologies Inc
A
| LOCK|<jsQk%k% | LOCK|Mv | $49B | |||
| IQVIA Holdings Inc
IQV
| LOCK|dF&kk% | LOCK|>Kvd | $46B | |||
| Waters Corp
WAT
| LOCK|<@y??m> | LOCK|$$ | $45B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|!#!Jj!g | LOCK|>R | $44B | |||
| Illumina Inc
ILMN
| LOCK|&Rhy&N | LOCK|%<V@< | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|^^&cp^h | LOCK|tTPGM | $33B | |||
| Quest Diagnostics Inc
DGX
| LOCK|<Zt^Pk | LOCK|^Gmby | $27B | |||
| Labcorp Holdings Inc
LH
| LOCK|nh>Z>?^ | LOCK|khKMf | $27B |
United States